MedTrace Logo

EXPAREL® for Pain After Tonsillectomy

NCT02444533 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2017-07-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether liposomal bupivacaine (long acting injectable anesthetic) provides greater post operative pain relief compared to the standard post operative pain regiment for tonsillectomy patients.

Conditions

  • Tonsillectomy
  • Tonsillitis
  • Post-operative Pain

Interventions

DRUG

Liposomal Bupivacaine

Injection of 8 ml of liposomal bupivacaine total in the tonsillar fossae after tonsillectomy.

Sponsors & Collaborators

Principal Investigators

  • Daniel L Price, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-05-31
Completion
2016-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02444533 on ClinicalTrials.gov